Review
Open access
Aug 2026
RETATRUTIDE IN INTERNAL MEDICINE: A NOVEL TRIPLE HORMONE RECEPTOR AGONIST FOR OBESITY, TYPE 2 DIABETES, AND CARDIOMETABOLIC RISK
Obesity and type 2 diabetes mellitus are major chronic diseases associated with cardiovascular, metabolic, hepatic, and renal complications. The development of incretin-based therapies has substantially changed the management of these conditions. Retatrutide is a novel once-weekly triple hormone receptor agonist that s...
Lívia de Oliveira Cardoso, Anny Karollynny Batista de Oliveira Neves, Gabriel Matheus D'Abadia França et al.
· International Journal of Sci... · 0 citations